Nirvana Life Sciences Inc. report that it has filed a new provisional patent application with the United States Patent and Trademark Office entitled Method of Psilocybin Extraction and Method of use of Psilocybin in modulating Heroin and Memory Retrieval (the "Patent Application"). The Patent Application contains new inventive claims for extraction as well as inventive methods for use of Psilocybin to affect relapse and further demonstrates the progress that the Company is making toward developing products that can have a meaningful impact on opioid addiction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -20.00% | -.--% | +100.00% |
1st Jan change | Capi. | |
---|---|---|
+100.00% | 1.41M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- NIRV Stock
- News Nirvana Life Sciences Inc.
- Nirvana Life Sciences Announces Patent Filing